Johns Hopkins ABX Guide
Saquinavir
INDICATIONS
FDA
FDA
- Treatment of HIV-infection in combination with other ARV agents.
- Saquinavir is no longer available in the U.S. The agent is not included in PEPFAR and does not appear on the WHO Essential Medications list.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 21, 2023
Citation
Dzintars, Kathryn, and Janessa Smith M Smith. "Saquinavir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540492/6/Saquinavir.
Dzintars K, Smith JM. Saquinavir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540492/6/Saquinavir. Accessed November 16, 2024.
Dzintars, K., & Smith, J. M. (2023). Saquinavir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540492/6/Saquinavir
Dzintars K, Smith JM. Saquinavir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. [cited 2024 November 16]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540492/6/Saquinavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Saquinavir
ID - 540492
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Smith,Janessa Smith,Pharm.D., BCPS
Y1 - 2023/03/21/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540492/6/Saquinavir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
